Cargando…

Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro

Hepatocellular carcinoma (HCC) frequently develops from hepatitis C virus (HCV) and hepatitis B virus (HBV) infection. We previously reported that peretinoin, an acyclic retinoid, inhibits HCV replication. This study aimed to examine the influence of peretinoin on the HBV lifecycle. HBV-DNA and cova...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murai, Kazuhisa, Shirasaki, Takayoshi, Honda, Masao, Shimizu, Ryogo, Shimakami, Tetsuro, Nakasho, Saki, Shirasaki, Natsumi, Okada, Hikari, Sakai, Yoshio, Yamashita, Taro, Kaneko, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855541/ https://www.ncbi.nlm.nih.gov/pubmed/29360739 http://dx.doi.org/10.3390/ijms19020108

Ejemplares similares

Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo
por: Funaki, Masaya, et al.
Publicado: (2017)

The Acyclic Retinoid Peretinoin Inhibits Hepatitis C Virus Replication and Infectious Virus Release in Vitro
por: Shimakami, Tetsuro, et al.
Publicado: (2014)

Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
por: Okada, Hikari, et al.
Publicado: (2017)

Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma
por: Honda, Masao, et al.
Publicado: (2013)

The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
por: Shirasaki, Takayoshi, et al.
Publicado: (2018)

Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma
por: Woo, Hyun Young, et al.
Publicado: (2021)

Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice
por: Shirasaki, Takayoshi, et al.
Publicado: (2021)

MicroRNA‐10a Impairs Liver Metabolism in Hepatitis C Virus‐Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator‐Like 1
por: Horii, Rika, et al.
Publicado: (2019)

Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems
por: Liu, Fanwei, et al.
Publicado: (2016)

Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulation
por: Wang, Zijing, et al.
Publicado: (2019)

Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection
por: Omura, Hitoshi, et al.
Publicado: (2019)

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
por: Takegoshi, Kai, et al.
Publicado: (2017)

Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial
por: Okita, Kiwamu, et al.
Publicado: (2014)

Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication
por: Kitabayashi, Juria, et al.
Publicado: (2020)

A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes
por: Sumiyadorj, Ariunaa, et al.
Publicado: (2022)

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET
por: Shirasaki, Takayoshi, et al.
Publicado: (2022)

Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice
por: Okada, Hikari, et al.
Publicado: (2015)

Guanine nucleotide exchange factor DOCK11-binding peptide fused with a single chain antibody inhibits hepatitis B virus infection and replication
por: Ide, Mayuko, et al.
Publicado: (2022)

Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2018)

Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C
por: Selitsky, Sara R., et al.
Publicado: (2015)

Functional involvement of endothelial lipase in hepatitis B virus infection
por: Shirasaki, Takayoshi, et al.
Publicado: (2023)

Hepatitis B Virus Utilizes a Retrograde Trafficking Route via the Trans-Golgi Network to Avoid Lysosomal Degradation
por: Li, Ying-Yi, et al.
Publicado: (2022)

Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
por: Wang, Xuyang, et al.
Publicado: (2017)

Identification of a Transmembrane Protein Involved in Shear Stress Signaling and Hepatocarcinogenesis After a Sustained Virological Response to Hepatitis C Virus
por: Nishikawa, Masashi, et al.
Publicado: (2023)

FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022)

Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells
por: Tatsukawa, Hideki, et al.
Publicado: (2011)

The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
por: Qin, Xian-Yang, et al.
Publicado: (2013)

Acyclic retinoid induces differentiation and apoptosis of murine hepatic stem cells
por: Guan, Hong-Bin, et al.
Publicado: (2015)

Regulation of the survival and differentiation of hepatic stem/progenitor cells by acyclic retinoid
por: Kamiya, Akihide
Publicado: (2015)

Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
por: Doan, Phuong Thi Bich, et al.
Publicado: (2023)

Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals
por: Li, Shihui, et al.
Publicado: (2022)

DOCK11 and DENND2A play pivotal roles in the maintenance of hepatitis B virus in host cells
por: Hashimoto, Shinichi, et al.
Publicado: (2021)

Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013)

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study
por: Okita, Kiwamu, et al.
Publicado: (2014)

Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
por: Yamashita, Taro, et al.
Publicado: (2022)

Met receptor is essential for MAVS-mediated antiviral innate immunity in epithelial cells independent of its kinase activity
por: Imamura, Ryu, et al.
Publicado: (2023)

A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma
por: Tamai, Toshikatsu, et al.
Publicado: (2020)

Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma
por: Hashiba, Tomomi, et al.
Publicado: (2020)

microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection
por: Spaniel, Carolyn, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hs1j6jvfphbv115hs2p5ljo31o